Trial intelligence / Profile preview

Myfortic dose escalation in kidney transplant recipients

NCT01044303Phase 4Completed

Sponsor
East Carolina University
Start
Jan 2010
Primary completion
Apr 2013
Countries
1
01

Overview

A Phase 4 trial of mycophenolate sodium in kidney transplant rejection, sponsored by East Carolina University. Started Jan 2010; status: completed.

02

Drugs

mycophenolate sodium
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT01044303.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01044303.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call